2025 annual financial data
Bolt Biotherapeutics 2025 Net income growth
Direct answer
Net income growth was 47.12%.
Operating income was -34,633,000 USD and net income was -33,376,000 USD.
Operating cash flow was -39,850,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,695,000 USD
- Operating income
- -34,633,000 USD
- Net income
- -33,376,000 USD
- Operating cash flow
- -39,850,000 USD